ZKB/PUT/ROCHE GS/225/0.02/28.06.24 Share Price

Warrant

ROG7QZ

CH1281035670

Delayed Swiss Exchange 16:20:00 17/06/2024 BST
0.01 CHF -33.33% Intraday chart for ZKB/PUT/ROCHE GS/225/0.02/28.06.24
Current month-71.43%
1 month-75.00%

Static data

Product typeWarrants
Buy / SellPUT
Underlying ROCHE HOLDING AG
Issuer ZKB
ROG7QZ
ISINCH1281035670
Date issued 19/10/2023
Strike 225 CHF
Maturity 28/06/2024 (1 Days)
Parity 50 : 1
Emission price 0.22 CHF
Emission volume N/A
Settlement Ambos
Currency CHF

Technical Indicators

Highest since issue 0.27 CHF
Lowest since issue 0.01 CHF
Delta-0.06x
Omega 30.36
Premium10.71x
Gearing478.86x
Moneyness 0.8950
Difference Strike -26.05 CHF
Difference Strike %-11.58%
Spread 0.019 CHF
Spread %95.00%
Theoretical value 0.0105
Implied Volatility 53.74 %
Total Loss Probability 92.75 %
Intrinsic value 0.000000
Present value 0.0105
Break even 224.48 CHF
Theta-0.01x
Vega0x
Rho-0x

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
249.6 CHF
Average target price
278.1 CHF
Spread / Average Target
+11.40%
Consensus
  1. Stock Market
  2. Warrants
  3. ROG7QZ Warrant